Table II.
Treatment Group | Total tissue area affected by granulomas (mm2) | |
---|---|---|
Lung | Spleen | |
BCG | 2.140 ± 0.356 | 0.255 ± 0.357 |
BCG–P-rAg85B | 1.102 ± 0.412a | 0.009 ± 0.011 |
BCG–BCG | 2.102 ± 0.581 | 0.007 ± 0.010 |
aSignificantly smaller than other vaccination groups